Science 37 Reports Third Quarter 2022 Financial Results
November 10, 2022 16:01 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022
November 01, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022...
Science 37 appoints Paul von Autenried to its Board of Directors
October 05, 2022 16:15 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the appointment of seasoned...
Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer
September 12, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced that Michael Shipton has been...
Science 37 to Present at the Baird 2022 Global Healthcare Conference
September 08, 2022 16:01 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be...
Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials
September 07, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a partnership with...
New Science 37 Technology Accelerates Patient Recruitment and Enrollment
August 24, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) today announced new patient relationship management and contact center technology to improve...
Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical Trials
August 18, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and Syapse®, a leading...
Science 37 Reports Second Quarter 2022 Financial Results
August 11, 2022 06:00 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022 07:55 ET
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., July 28, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report second quarter...